Reagents and methods for identifying gene targets for...

Details Reagents and methods for identifying gene targets for... Reagents and methods for identifying gene targets for...

2007-06-26

2007-06-26

Martinell, James (Department: 1634)

Chemistry: analytical and immunological testing

Process or composition for determination of physical state...

Corrosion resistance or power

C435S007100, C435S004000, C435S029000

Reexamination Certificate

active

10199820

ABSTRACT:
The invention provides methods and reagents for identifying mammalian genes necessary for tumor cell growth as targets for developing drugs that inhibit expression of said genes and inhibit tumor cell growth thereby.

REFERENCES:
patent: 5217889 (1993-06-01), Roninson et al.
patent: 5654168 (1997-08-01), Bujard et al.
patent: 5665550 (1997-09-01), Roninson et al.
patent: 5753432 (1998-05-01), Gudkov et al.
patent: 5811234 (1998-09-01), Roninson et al.
patent: 5851796 (1998-12-01), Schatz
patent: 5866328 (1999-02-01), Bensimon et al.
patent: 5942389 (1999-08-01), Kirschling et al.
patent: 5968773 (1999-10-01), Heddle et al.
patent: 6043340 (2000-03-01), Gudkov et al.
patent: 6060134 (2000-05-01), Mesch
patent: 6083745 (2000-07-01), Gudkov et al.
patent: 6083746 (2000-07-01), Gudkiv et al.
patent: 6197521 (2001-03-01), Roninson et al.
patent: 6268134 (2001-07-01), Roninson et al.
patent: 6281011 (2001-08-01), Roninson et al.
patent: 6326488 (2001-12-01), Roninson et al.
patent: WO/01 38532 (2001-05-01), None
Araki et al., “Identification of Genes Induced in Peripheral Nerve after Injury”J. Biol. Chem.276:34131-41 (Sep. 7, 2001).
Barnes and Gillett “Cyclin D1 in breast cancer”Breast Cancer Res. Treat.52:1-15 (1998).
Castets et al., “Zinedin, SG2NA, and Striatin Are Calmodulin-binding, WD Repeat Proteins Principally Expressed in the Brain”J. Biol. Chem.275:19970-77 (2000).
Chang et al., “Role of p53 and p21wal1/cip1in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs”Oncogene18:4808-18 (1999).
Dahme et al., “Disruption of the mouse L1 gene leads to malformations of the nervous system”Nat. Genet.17:346-349 (1997).
Denis et al., “A mouse model of severe von Willebrand disease: Defects in hemostasis and thrombosis”Proc. Natl. Acad. Sci.USA 95:9524-29 (1998).
Fruchtel & Jung, Organic Chemistry on Solid Supports:Angew. Chem. Int. Ed. Engl.35:17-42 (1996).
Gallop et al., “Applications of Combinatorial Technologies to Drug Discovery. 1. Background and Peptide Combination Libraries”J. Med. Chem.37:1233-51 (Apr. 29, 1994).
Gerwin et al., “Prolonged Eosinophil Accumulation in Allergic Lung Interstitium of ICAM-2-Deficient Mice Results in Extended Hyperresponsiveness”Immunity10:9-19 (1999).
Gudkov et al., “Cloning mammalian genes by expression selection of genetic suppressor elements: Association of kinesin with drug resistance and cell immortalization”Proc. Natl. Sci.USA 91:3744-48 (1994).
Hettmann et al., “Microphthalmia Due to p53-Mediated Apoptosis of Anterior Lens Epithelial Cells in Mice Lacking the CREB-2 Transcription Factor”Dev. Biol.222-110-23 (2000).
Izumoto et al., “Gene Expression of Neural Cell Adhesion Molecule L1 Malignant Gliomas and Biological Significance of L1 in Glioma Invasion”Cancer Research56:1440-44 (Mar. 15, 1996).
Jacquemier et al., “Expression of the FGFR1 Gene in Human Breast-Carcinoma Cells”Int. J. Cancer59:373-378 (1994).
Jameel et al., “Clinical and Biological Significance of HSP89 Alpha in Human Breast Cancer”Int. J. Cancer50:409-415 (1992).
Kent et al., “Chemical Synthesis of Peptides and Proteins”Ann. Rev. Biochem.57:957-89 (1988).
McPherson et al., “Current approaches to marcromolecular crystallization”Eur. J. Biochem.189:1-124.
Munster et al., “Inhibition of Heat Shock Protein 90 Function by Ansamycins Causes the Morphological and Functional Differentiation of Breast Cancer Cells”Cancer Res.61:2945-52 (2001).
Munster et al., “Modulation of Hsp90 Function by Ansamycins Sensitizes Breast Cancer Cells to Chemotherapy-induced Apoptosis in an RB-and Schedule-dependent Manner”Clin. Cancer Res.2228-36 (2001).
O'Conner “Mammalian G1and G2Phase Checkpoints”Cancer Surv.29:151-182 (1997).
Patanjali et al., “Constuction of a uniform-abundance (normalized) cDNA library”Proc. Natl. Acad. Sci.USA 88:1943-47 (1991).
Pestov et al., “Genetic selection of growth-inhibitory sequences in mammalian cells”Proc. Natl. Acad. Sci.USA 91:12549-53 (1994).
Pestov et al., “Isolation of growth suppressors from a cDNA expression library”Oncogene17:13187-3197.
Peters et al., “Activation of cellular gene by mouse mammalry tumor virus may occur early in mammary tumour development”Nature309:273-275 (1984).
Pihan et al., “The mitotic machinery as a source of genetic instability in cancer”Semin. Cancer Biol.9:289-302 (1999).
Scolnick et al., “Chfrdefines a mitotic stress checkpoint that delays entry into metaphase”Nature406:430-435 (2000).
Talukder et al., “Heregulin Induces Expression, DNA Binding Activity, and Transactivating Functions of Basic Leucine Zipper Activating Transcription Factor 41”Cancer Res.60:276-281 (2000).
Tanaka et al., “Targeted disruption of ATF4 discloses its essential role on the formation eye lens fibres”Genes Cells3:801-810 (1998).
Thompson & Ellman, “Synthesis and Applications of Small Molecule Libraries”Chem. Rev.96:555-6000 (1996).
Torres and Horwitz “Mechanisms of Taxol-induced Cell Death Are Concentration Dependent”Cancer Res.58:3620-3626 (1998).

Affiliated with

Also associated with

Rating

Reagents and methods for identifying gene targets for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Reagents and methods for identifying gene targets for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reagents and methods for identifying gene targets for... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3849477